›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Oncomine Dx Express Test
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Thermo Fisher ScientificType:
CE Marked
Related tests:
Oncomine Dx Express Test detects clinically relevant biomarkers per professional medical guidelines1, including ESCAT for clinically relevant biomarkers and approved therapies. The test substitutions, insertions and deletions, copy number variants, and rearrangements or fusions across 46 genes including EGFR, BRAF, KRAS, ERBB2, MET, ALK, ROS1, RET, MET, and NTRK1/2/3, among others.
Cancer:
Non Small Cell Lung Cancer
Gene:
ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase)
See More ...
ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3), RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
Method:
Next-Generation Sequencing (NGS)